EDGAR Filing Documents for 0001079973-23-000326

Form 8-K - Current report:

SEC Accession No. 0001079973-23-000326

Filing Date

2023-03-13

Accepted

2023-03-13 17:00:21

Documents

Period of Report

2023-03-08

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	cdio_8k.htm iXBRL	8-K	49986
2	FIRST CONVERTIBLE DEBENTURE	ex4x1.htm	EX-4.1	118633
3	SECURITIES PURCHASE AGREEMENT	ex10x1.htm	EX-10.1	278567
4	FORM OF CONVERTIBLE DEBENTURE	ex10x2.htm	EX-10.2	119225
5	REGISTRATION RIGHTS AGREEMENT	ex10x3.htm	EX-10.3	86598
6	PRESS RELEASE	ex99x1.htm	EX-99.1	10227
	Complete submission text file	0001079973-23-000326.txt		1034358

Data Files

Seq	Description	Document	Type	Size
7	XBRL SCHEMA FILE	cdio-20230308.xsd	EX-101.SCH	4065
8	XBRL DEFINITION FILE	cdio-20230308_def.xml	EX-101.DEF	26726
9	XBRL LABEL FILE	cdio-20230308_lab.xml	EX-101.LAB	36860
10	XBRL PRESENTATION FILE	cdio-20230308_pre.xml	EX-101.PRE	25350
12	EXTRACTED XBRL INSTANCE DOCUMENT	cdio_8k_htm.xml	XML	5762

Mailing Address 400 N ABERDEEN ST, SUITE 900 CHICAGO IL 60642

Business Address 400 N ABERDEEN ST, SUITE 900 CHICAGO IL 60642 855-226-9991

Cardio Diagnostics Holdings, Inc. (Filer) CIK: 0001870144 (see all company filings)

IRS No.: 870925574 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41097 | Film No.: 23728042
SIC: 2835 In Vitro & In Vivo Diagnostic Substances